According to estimating the relationship between AARS2 and tumor biological activity and clinical transformation, the AARS2 performed as an oncogenic gene in HCC and could be a promising biomarker for prognosis and immunotherapy in human cancers. The gene discussed is AARS2; the disease is hepatocellular carcinoma.